monday.com (MNDY)
(Delayed Data from NSDQ)
$287.31 USD
+1.45 (0.51%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $286.02 -1.29 (-0.45%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$287.31 USD
+1.45 (0.51%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $286.02 -1.29 (-0.45%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth B Momentum B VGM
Zacks News
StoneCo Ltd. (STNE) to Report Q3 Results: Wall Street Expects Earnings Growth
by Zacks Equity Research
StoneCo Ltd. (STNE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Monday.com (MNDY) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Monday.com (MNDY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Datadog (DDOG) Q3 Earnings Rise Y/Y, Revenues Beat Estimates
by Zacks Equity Research
Datadog's (DDOG) third-quarter 2022 top-line results benefit from the strong adoption of existing and new products and features.
Monday.com (MNDY) Expands in North America With Chicago Office
by Zacks Equity Research
Monday.com (MNDY) further expands its presence in North America as it has opened its latest office in Chicago.
Monday.com (MNDY) Expands in Japan With Local Tokyo Team
by Zacks Equity Research
Monday.com (MNDY) expands its presence in Japan as it opens a new office in Tokyo in partnership with a local team.
Monday.com (MNDY) Soars 4.4%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Monday.com (MNDY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
How Much Upside is Left in Monday.com (MNDY)? Wall Street Analysts Think 54%
by Zacks Equity Research
The mean of analysts' price targets for Monday.com (MNDY) points to a 53.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Bears are Losing Control Over Monday.com (MNDY), Here's Why It's a 'Buy' Now
by Zacks Equity Research
Monday.com (MNDY) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Wall Street Analysts See a 28% Upside in Monday.com (MNDY): Can the Stock Really Move This High?
by Zacks Equity Research
The consensus price target hints at a 28.3% upside potential for Monday.com (MNDY). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Monday.com (MNDY) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Monday.com (MNDY) delivered earnings and revenue surprises of 56% and 4.70%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Evolent Health (EVH) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Evolent Health (EVH) delivered earnings and revenue surprises of 233.33% and 9.08%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
monday.com (MNDY) Q1 Earnings Top Estimates, Revenues Up Y/Y
by Zacks Equity Research
monday.com's (MNDY) first-quarter 2022 results reflect an expanding customer base and strong demand for its solutions.